Welcome to LookChem.com Sign In|Join Free

CAS

  • or

12656-11-0

Post Buying Request

12656-11-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

12656-11-0 Usage

Uses

Innohep (Pharmion).

Clinical Use

Peri- and postoperative surgical thromboprophylaxis Treatment of DVT and pulmonary embolism Prevention of thrombus formation in extracorporeal circulation during HD

Drug interactions

Potentially hazardous interactions with other drugs Analgesics: increased risk of bleeding with NSAIDs - avoid concomitant use with IV diclofenac; increased risk of haemorrhage with ketorolac - avoid concomitant use. Nitrates: anticoagulant effect reduced by infusions of glyceryl trinitrate. Use with care in patients receiving oral anticoagulants, platelet aggregation inhibitors, aspirin or dextran.

Metabolism

Low molecular weight heparins are partially metabolised by desulphation and depolymerisation. The kidneys are the major site of tinzaparin excretion (approximately 70% based on animal studies).

Check Digit Verification of cas no

The CAS Registry Mumber 12656-11-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,2,6,5 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 12656-11:
(7*1)+(6*2)+(5*6)+(4*5)+(3*6)+(2*1)+(1*1)=90
90 % 10 = 0
So 12656-11-0 is a valid CAS Registry Number.

12656-11-0Upstream product

12656-11-0Downstream Products

12656-11-0Related news

TINZAPARIN SODIUM (cas 12656-11-0) for thrombosis treatment and prevention during pregnancy☆08/17/2019

ObjectiveThis study was undertaken to assess the pharmacodynamic profile, safety, and efficacy of tinzaparin during pregnancy.detailed

A spectroscopic and molecular docking approach on the binding of TINZAPARIN SODIUM (cas 12656-11-0) with human serum albumin08/16/2019

Protein bound toxins are poorly removed by conventional extracorporeal therapies. Venous thromboembolism (VTE) is a major cause of morbidity and mortality in patients with cancer. The interaction between tinzaparin, an inhibitor of angiotensin converting enzyme and human serum albumin, a princip...detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 12656-11-0